title: 1p36 tumor suppression--a matter of dosage?
abstract: A broad range of human malignancies is associated with nonrandom 1p36 deletions, suggesting the existence of tumor suppressors encoded in this region. Evidence for tumor-specific inactivation of 1p36 genes in the classic "two-hit" manner is scarce; however, many tumor suppressors do not require complete inactivation but contribute to tumorigenesis by partial impairment. We discuss recent data derived from both human tumors and functional cancer models indicating that the 1p36 genes CHD5, CAMTA1, KIF1B, CASZ1, and miR-34a contribute to cancer development when reduced in dosage by genomic copy number loss or other mechanisms. We explore potential interactions among these candidates and propose a model where heterozygous 1p36 deletion impairs oncosuppressive pathways via simultaneous downregulation of several dosage-dependent tumor suppressor genes.
authors.affiliation: Division of Tumor Genetics B030, German Cancer Research Center, Heidelberg, Germany. k.henrich@dkfz.de
authors.forename: Kai-Oliver
authors.initials: KO
authors.lastname: Henrich
authors.forename: Manfred
authors.initials: M
authors.lastname: Schwab
authors.forename: Frank
authors.initials: F
authors.lastname: Westermann
mesh_terms: D000818:Animals; D002872:Chromosome Deletion; D025063:Chromosome Disorders / Q000235:genetics*; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D018628:Gene Dosage; D016147:Genes, Tumor Suppressor; D006801:Humans; D009369:Neoplasms / Q000235:genetics*